Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

iTherapeutics Corporation
Profile last edited on: 10/27/2008      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
----
First Award
2008
Latest Award
2010
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

3701 FAU Boulevard Suite 210-112
Boca Raton, FL 33431
   (561) 542-1380
   rwilliams@itherapeutics.com
   www.itherapeutics.com
Location: Single
Congr. District: 22
County: Palm Beach

Public Profile

iTherapeutics is a biotechnology company specializing in the development of novel RNAi-based therapies to treat the wet form of age-related macular degeneration (AMD). AMD is the leading cause of vision loss in people (age >65). The prevalence of wet AMD and/or geographic atrophy increases dramatically with age. About 1.5% of the US population over 40 years of age (approx. 1.7 million) is estimated to have wet AMD.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$147,275
Phase II Dollars
$137,837
Total Awarded
$285,112

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2010 1 NIH $285,112
Project Title: Mt1-Mmp-Based Animal Model Of Age-Related Macular Degeneration (Amd)

Key People / Management

  George Inana

Company News

There are no news available.